Index RUT P/E - EPS (ttm) - Insider Own 51.57% Shs Outstand 33.38M Perf Week 21.02%
Market Cap 363.58M Forward P/E - EPS next Y - Insider Trans 107.58% Shs Float 16.19M Perf Month 0.28%
Income - PEG - EPS next Q -0.57 Inst Own 50.09% Short Float 17.29% Perf Quarter -33.74%
Sales - P/S - EPS this Y - Inst Trans 28.96% Short Ratio 9.36 Perf Half Y -
Book/sh 8.13 P/B 1.34 EPS next Y - ROA - Short Interest 2.80M Perf Year -
Cash/sh 8.29 P/C 1.31 EPS next 5Y - ROE - 52W Range 8.63 - 27.50 Perf YTD -40.97%
Dividend Est. - P/FCF - EPS past 5Y - ROI - 52W High -60.44% Beta -
Dividend TTM - Quick Ratio 25.75 Sales past 5Y 0.00% Gross Margin - 52W Low 26.06% ATR (14) 1.46
Dividend Ex-Date - Current Ratio 25.75 EPS Y/Y TTM - Oper. Margin - RSI (14) 45.52 Volatility 12.00% 13.23%
Employees - Debt/Eq 0.00 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 37.25
Option/Short No / Yes LT Debt/Eq 0.00 EPS Q/Q -138.42% Payout - Rel Volume 0.51 Prev Close 11.83
Sales Surprise - EPS Surprise -2.33% Sales Q/Q - Earnings Nov 07 BMO Avg Volume 299.07K Price 10.88
SMA20 1.53% SMA50 -25.08% SMA200 -41.29% Trades
Volume 151,788 Change -8.03%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-08-24 Initiated Stifel
Buy
$40
Oct-08-24 Initiated JP Morgan
Overweight
$30
Oct-08-24 Initiated Jefferies
Buy
$35
Oct-08-24 Initiated Guggenheim
Buy
$44
Feb-18-25 08:00AM
Jan-23-25 08:00AM
Jan-07-25 11:47AM
07:00AM
Dec-18-24 08:00AM
08:00AM
Loading…
Dec-02-24 08:00AM
Nov-18-24 08:00AM
Nov-07-24 08:00AM
Oct-28-24 08:00AM
Oct-14-24 06:45AM
Sep-30-24 08:00AM
Sep-23-24 07:05PM
Sep-18-24 03:19AM
Sep-16-24 04:05PM
Sep-12-24 07:11PM
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GORDON CARL L Director Feb 18 '25 Buy 10.84 143,170 1,551,963 3,255,000 Feb 19 05:56 PM GORDON CARL L Director Feb 14 '25 Buy 9.87 47,502 468,793 3,205,930 Feb 19 05:56 PM ORBIMED ADVISORS LLC Director Feb 18 '25 Buy 10.84 143,170 1,551,963 3,255,000 Feb 19 05:52 PM ORBIMED ADVISORS LLC Director Feb 14 '25 Buy 9.87 47,502 468,793 3,205,930 Feb 19 05:52 PM Hawryluk P. Kent President & CEO Feb 04 '25 Buy 10.69 50,000 534,500 448,277 Feb 05 04:17 PM Mathers Edward T Director Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:28 PM BASKETT FOREST 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:26 PM Behbahani Ali 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:24 PM Chang Carmen 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:23 PM Florence Anthony A. Jr. 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:21 PM Makhzoumi Mohamad 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:20 PM Walker Paul Edward 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:18 PM Yang Rick 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:17 PM SANDELL SCOTT D 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:14 PM ORBIMED ADVISORS LLC Director Sep 16 '24 Buy 16.00 750,000 12,000,000 3,158,428 Sep 17 08:13 PM New Enterprise Associates 17, 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:12 PM Frazier Life Sciences X, L.P. 10% Owner Sep 16 '24 Buy 16.00 625,000 10,000,000 4,552,774 Sep 17 08:11 PM Heron Patrick J Director Sep 16 '24 Buy 16.00 625,000 10,000,000 4,552,774 Sep 17 08:09 PM Aynechi Tiba Director Sep 16 '24 Buy 16.00 750,000 12,000,000 2,136,335 Sep 17 08:05 PM GORDON CARL L Director Sep 16 '24 Buy 16.00 750,000 12,000,000 3,158,428 Sep 17 08:05 PM
Index RUT P/E - EPS (ttm) -12.02 Insider Own 41.68% Shs Outstand 9.32M Perf Week -9.59%
Market Cap 246.29M Forward P/E - EPS next Y -9.74 Insider Trans -0.28% Shs Float 5.46M Perf Month -31.02%
Income -101.60M PEG - EPS next Q -2.50 Inst Own 68.84% Short Float 14.41% Perf Quarter -43.62%
Sales 0.00M P/S - EPS this Y 82.58% Inst Trans 22.27% Short Ratio 8.42 Perf Half Y -37.85%
Book/sh 19.28 P/B 1.36 EPS next Y -5.31% ROA -70.10% Short Interest 0.79M Perf Year -53.04%
Cash/sh 14.81 P/C 1.77 EPS next 5Y 44.45% ROE -93.91% 52W Range 28.28 - 98.00 Perf YTD -30.94%
Dividend Est. - P/FCF - EPS past 5Y -11.67% ROI -45.89% 52W High -73.17% Beta 3.81
Dividend TTM - Quick Ratio 11.23 Sales past 5Y -33.55% Gross Margin - 52W Low -7.04% ATR (14) 2.46
Dividend Ex-Date - Current Ratio 11.23 EPS Y/Y TTM 85.54% Oper. Margin - RSI (14) 29.17 Volatility 5.60% 6.98%
Employees 101 Debt/Eq 0.23 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 136.86
Option/Short No / Yes LT Debt/Eq 0.23 EPS Q/Q 85.65% Payout - Rel Volume 0.89 Prev Close 28.65
Sales Surprise - EPS Surprise 10.56% Sales Q/Q - Earnings Nov 12 AMC Avg Volume 93.45K Price 26.29
SMA20 -19.88% SMA50 -30.81% SMA200 -41.05% Trades
Volume 83,611 Change -8.24%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-10-25 Initiated Oppenheimer
Outperform
$155
Oct-21-24 Initiated Raymond James
Strong Buy
$153
Aug-14-24 Initiated William Blair
Outperform
$180
Mar-28-24 Reiterated H.C. Wainwright
Buy
$100 → $115
Feb-27-24 Initiated BMO Capital Markets
Outperform
$120
Dec-04-23 Initiated H.C. Wainwright
Buy
$100
Nov-29-23 Initiated RBC Capital Mkts
Outperform
$70
Nov-10-23 Initiated Piper Sandler
Overweight
$180
Feb-15-23 Downgrade Chardan Capital Markets
Buy → Neutral
Feb-13-23 Downgrade Cowen
Outperform → Market Perform
Sep-22-21 Downgrade Goldman
Buy → Neutral
$12 → $9
Jan-27-21 Upgrade JP Morgan
Neutral → Overweight
$56
Dec-22-20 Initiated B. Riley Securities
Buy
$79
Jul-14-20 Initiated Oppenheimer
Outperform
$36
May-18-20 Downgrade JP Morgan
Overweight → Neutral
$27
Oct-28-19 Initiated JP Morgan
Overweight
$25
Oct-28-19 Initiated Goldman
Buy
$30
Oct-28-19 Initiated Cowen
Outperform
Show Previous Ratings
Jan-13-25 08:00AM
Jan-07-25 08:00AM
Dec-10-24 08:00AM
Nov-21-24 04:01PM
07:30AM
08:00AM
Loading…
Nov-14-24 08:00AM
Nov-12-24 04:05PM
(GlobeNewswire) -11.37%
-15.55%
Nov-04-24 07:25AM
Oct-21-24 04:15PM
(Investor's Business Daily) -5.22%
-7.70%
Oct-16-24 04:20PM
(Investor's Business Daily) +93.66%
Sep-30-24 08:00AM
Sep-16-24 08:00AM
Sep-10-24 08:00AM
Aug-28-24 08:00AM
Aug-27-24 08:00AM
04:01PM
Loading…
Aug-13-24 04:01PM
Jul-01-24 08:00AM
Jun-25-24 12:53PM
May-30-24 04:01PM
May-20-24 02:30PM
May-14-24 10:55PM
04:01PM
Apr-18-24 08:30AM
Apr-01-24 04:01PM
Mar-26-24 04:01PM
Feb-27-24 09:55AM
08:00AM
Feb-09-24 09:55AM
Jan-18-24 08:00AM
Jan-04-24 08:00AM
08:00AM
Loading…
Dec-07-23 08:00AM
Nov-28-23 08:00AM
Nov-03-23 03:31PM
12:19PM
Aug-10-23 04:01PM
Jul-17-23 11:59AM
Jul-14-23 11:22AM
06:30AM
May-12-23 04:01PM
Mar-10-23 07:30AM
Feb-27-23 07:30AM
Feb-13-23 01:55PM
(American City Business Journals) -80.54%
11:17AM
08:05AM
Dec-19-22 07:30AM
Dec-15-22 07:30AM
Nov-17-22 07:30AM
Nov-08-22 04:05PM
Oct-12-22 07:30AM
Aug-30-22 07:30AM
Aug-09-22 04:05PM
(Business Wire) -11.11%
+9.00%
Jun-24-22 09:03AM
May-25-22 12:00PM
May-18-22 07:30AM
May-04-22 04:30PM
Apr-22-22 07:30AM
Apr-08-22 05:00PM
Mar-15-22 07:30AM
Mar-10-22 06:35PM
Feb-28-22 07:30AM
Jan-14-22 05:43AM
Jan-04-22 07:30AM
Dec-28-21 02:38AM
Dec-09-21 01:18PM
07:30AM
Nov-30-21 05:53AM
Nov-15-21 12:25PM
07:30AM
Nov-09-21 07:30AM
Nov-08-21 03:00PM
Oct-27-21 07:30AM
Oct-21-21 07:30AM
Oct-01-21 08:23AM
Sep-22-21 11:18AM
07:30AM
Sep-08-21 07:30AM
Aug-30-21 05:10PM
Aug-12-21 04:06PM
08:45AM
07:30AM
Aug-04-21 03:00PM
Aug-02-21 03:05PM
02:30PM
12:30PM
12:30PM
11:00AM
10:00AM
09:16AM
09:09AM
05:50AM
03:27AM
Aug-01-21 10:38AM
06:36AM
Jul-30-21 08:49PM
07:19PM
07:10PM
05:15PM
02:57PM
01:30PM
12:40PM
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Agarwal Vineet Chief Financial Officer Nov 11 '24 Option Exercise 11.68 800 9,344 800 Nov 12 07:40 PM Agarwal Vineet Chief Financial Officer Nov 11 '24 Sale 70.00 800 56,000 0 Nov 12 07:40 PM Agarwal Vineet Officer Nov 11 '24 Proposed Sale 70.00 800 56,000 Nov 12 08:28 AM Agarwal Vineet Chief Financial Officer Oct 17 '24 Option Exercise 11.99 10,216 122,468 10,216 Oct 18 07:43 PM Agarwal Vineet Chief Financial Officer Oct 17 '24 Sale 78.26 10,216 799,527 0 Oct 18 07:43 PM Agarwal Vineet Officer Oct 17 '24 Proposed Sale 78.26 10,216 799,527 Oct 17 04:22 PM Colletti Steve Former Officer Oct 16 '24 Proposed Sale 88.67 13,821 1,225,450 Oct 16 01:05 PM Colletti Steve Former Officer Aug 30 '24 Proposed Sale 49.24 10,303 507,326 Aug 30 05:28 PM New Enterprise Associates 17, 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM BASKETT FOREST 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Florence Anthony A. Jr. 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Walker Paul Edward 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Chang Carmen 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Mathers Edward T 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Yang Rick 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Makhzoumi Mohamad 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM SANDELL SCOTT D 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Atlas Venture Opportunity Fund 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 195,074 Apr 23 05:23 PM
Index - P/E - EPS (ttm) -0.23 Insider Own 12.47% Shs Outstand 307.89M Perf Week -13.90%
Market Cap 52.07B Forward P/E 149.72 EPS next Y 1.01 Insider Trans -3.79% Shs Float 299.95M Perf Month 23.45%
Income -78.80M PEG - EPS next Q 0.16 Inst Own 77.94% Short Float 2.65% Perf Quarter 64.65%
Sales 1.67B P/S 31.19 EPS this Y 6.45% Inst Trans -0.55% Short Ratio 2.34 Perf Half Y 84.57%
Book/sh 3.03 P/B 50.09 EPS next Y 27.14% ROA -2.60% Short Interest 7.95M Perf Year 55.08%
Cash/sh 5.43 P/C 27.99 EPS next 5Y 23.75% ROE -8.71% 52W Range 66.24 - 177.37 Perf YTD 41.12%
Dividend Est. - P/FCF 316.04 EPS past 5Y 8.13% ROI -3.20% 52W High -14.32% Beta 1.28
Dividend TTM - Quick Ratio 2.86 Sales past 5Y 42.55% Gross Margin 77.30% 52W Low 129.41% ATR (14) 7.10
Dividend Ex-Date - Current Ratio 2.86 EPS Y/Y TTM 58.13% Oper. Margin -9.23% RSI (14) 54.76 Volatility 4.33% 4.67%
Employees 4263 Debt/Eq 1.40 Sales Y/Y TTM 28.76% Profit Margin -4.72% Recom 2.47 Target Price 151.54
Option/Short Yes / Yes LT Debt/Eq 1.35 EPS Q/Q 54.83% Payout - Rel Volume 1.07 Prev Close 156.38
Sales Surprise 1.75% EPS Surprise 5.61% Sales Q/Q 26.89% Earnings Feb 06 AMC Avg Volume 3.40M Price 151.96
SMA20 0.09% SMA50 17.79% SMA200 60.97% Trades
Volume 3,651,864 Change -2.83%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-11-25 Downgrade DZ Bank
Hold → Sell
$145
Feb-07-25 Downgrade Oppenheimer
Outperform → Perform
Feb-03-25 Downgrade Robert W. Baird
Outperform → Neutral
$125 → $140
Jan-17-25 Upgrade Citigroup
Neutral → Buy
$95 → $145
Jan-17-25 Initiated Cantor Fitzgerald
Neutral
$111
Jan-03-25 Reiterated RBC Capital Mkts
Outperform
$99 → $123
Jan-02-25 Upgrade Goldman
Sell → Buy
$77 → $140
Dec-17-24 Upgrade Stifel
Hold → Buy
$95 → $136
Dec-02-24 Upgrade Morgan Stanley
Equal-Weight → Overweight
Oct-08-24 Initiated Exane BNP Paribas
Underperform
$65
Jul-16-24 Initiated Wolfe Research
Peer Perform
Jul-08-24 Initiated Scotiabank
Sector Perform
$85
Jun-25-24 Upgrade UBS
Sell → Neutral
$76 → $82
May-07-24 Upgrade DZ Bank
Hold → Buy
$95
Feb-13-24 Downgrade DZ Bank
Buy → Hold
$110
Feb-09-24 Resumed Cantor Fitzgerald
Neutral
$100
Jan-18-24 Initiated Bernstein
Mkt Perform
$85
Jan-17-24 Initiated CapitalOne
Equal Weight
$83
Dec-15-23 Initiated Susquehanna
Neutral
$75
Nov-21-23 Upgrade Oppenheimer
Perform → Outperform
Show Previous Ratings
Feb-21-25 09:00AM
Feb-19-25 04:34PM
08:02AM
Feb-13-25 04:15PM
07:30AM
08:09AM
Loading…
Feb-12-25 08:09AM
Feb-10-25 04:57PM
03:02PM
01:00PM
12:52PM
10:18AM
09:00AM
Feb-08-25 04:36PM
04:22PM
09:30AM
09:11AM
Loading…
09:11AM
09:11AM
06:30AM
04:00AM
Feb-07-25 06:39PM
04:25PM
03:15PM
03:07PM
02:35PM
02:12PM
12:10PM
11:05AM
10:50AM
10:46AM
10:46AM
10:15AM
Loading…
10:15AM
09:53AM
09:46AM
(Thomson Reuters StreetEvents)
09:38AM
08:14AM
08:05AM
(Investor's Business Daily)
05:27AM
02:27AM
12:15AM
Feb-06-25 05:40PM
05:35PM
(Investor's Business Daily)
04:55PM
(Investor's Business Daily)
04:39PM
04:36PM
(Associated Press Finance)
04:24PM
04:15PM
12:39PM
Feb-05-25 09:00AM
08:02AM
Feb-04-25 11:10AM
10:50AM
Feb-03-25 04:14PM
01:19PM
10:57AM
10:08AM
09:00AM
Jan-30-25 05:50PM
02:06PM
Jan-29-25 10:00AM
05:30AM
(The Wall Street Journal)
04:24AM
02:46AM
Jan-28-25 05:01PM
03:48PM
01:05PM
Jan-27-25 05:49PM
03:43PM
(Investor's Business Daily)
02:14PM
09:50AM
04:30AM
Jan-24-25 04:03PM
(Investor's Business Daily)
01:04PM
09:00AM
Jan-23-25 06:00PM
09:15AM
Jan-22-25 04:01AM
Jan-21-25 03:17PM
02:05PM
04:01AM
Jan-20-25 04:44PM
Jan-17-25 04:06PM
(Investor's Business Daily)
03:23PM
(Investor's Business Daily)
01:20PM
11:41AM
09:45AM
Jan-16-25 06:00PM
Jan-14-25 04:01AM
Jan-13-25 09:00AM
Jan-11-25 05:37AM
Jan-09-25 05:50PM
04:15PM
09:50AM
Jan-08-25 04:01AM
Jan-07-25 10:34AM
Jan-06-25 10:07PM
06:00PM
Jan-03-25 12:16PM
Jan-02-25 03:54PM
01:33PM
01:30PM
Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zatlyn Michelle President and Board Co-Chair Feb 19 '25 Sale 164.84 35,099 5,785,547 0 Feb 21 09:20 PM Zatlyn Michelle President and Board Co-Chair Feb 20 '25 Sale 156.91 25,640 4,023,254 0 Feb 21 09:20 PM Zatlyn Michelle President and Board Co-Chair Feb 21 '25 Sale 156.67 25,640 4,016,929 0 Feb 21 09:20 PM Riley Janel Chief Accounting Officer Feb 18 '25 Sale 167.60 4,327 725,196 74,698 Feb 19 06:16 PM SEIFERT THOMAS J Chief Financial Officer Feb 19 '25 Sale 162.07 28,635 4,640,912 293,582 Feb 19 06:14 PM Michelle Zatlyn Officer Feb 19 '25 Proposed Sale 160.59 240,219 38,576,769 Feb 19 04:52 PM THOMAS J SEIFERT Officer Feb 19 '25 Proposed Sale 168.81 28,635 4,833,874 Feb 19 04:30 PM SEIFERT THOMAS J Chief Financial Officer Feb 03 '25 Sale 136.63 15,000 2,049,447 252,869 Feb 05 06:39 PM Kramer Douglas James Chief Legal Officer Feb 03 '25 Sale 131.66 2,481 326,648 175,688 Feb 05 06:00 PM THOMAS J SEIFERT Officer Feb 03 '25 Proposed Sale 138.40 15,000 2,076,000 Feb 03 04:18 PM DOUGLAS KRAMER Officer Feb 03 '25 Proposed Sale 131.66 2,481 326,648 Feb 03 04:07 PM Zatlyn Michelle President and COO Jan 24 '25 Sale 123.75 25,640 3,172,847 0 Jan 24 08:09 PM Zatlyn Michelle President and COO Jan 23 '25 Sale 122.89 25,640 3,150,898 0 Jan 24 08:09 PM Zatlyn Michelle President and COO Jan 22 '25 Sale 120.40 25,640 3,087,055 0 Jan 24 08:09 PM SEIFERT THOMAS J Chief Financial Officer Jan 17 '25 Sale 119.40 33,864 4,043,490 252,869 Jan 21 04:47 PM SEIFERT THOMAS J Chief Financial Officer Jan 21 '25 Sale 120.10 31,136 3,739,381 252,869 Jan 21 04:47 PM THOMAS J SEIFERT Officer Jan 21 '25 Proposed Sale 117.16 31,136 3,647,894 Jan 21 04:22 PM THOMAS J SEIFERT Officer Jan 17 '25 Proposed Sale 114.82 33,864 3,888,264 Jan 17 04:19 PM Prince Matthew CEO & Chair of the Board Jan 07 '25 Sale 114.72 52,384 6,009,539 10,762 Jan 08 08:41 PM Prince Matthew CEO & Chair of the Board Jan 06 '25 Sale 113.98 52,384 5,970,937 10,762 Jan 08 08:41 PM Prince Matthew CEO & Chair of the Board Jan 08 '25 Sale 113.73 52,384 5,957,673 10,762 Jan 08 08:41 PM SEIFERT THOMAS J Chief Financial Officer Jan 03 '25 Sale 113.81 15,000 1,707,161 252,869 Jan 06 04:59 PM Kramer Douglas James Chief Legal Officer Jan 02 '25 Sale 112.45 9,000 1,012,072 175,688 Jan 06 04:42 PM THOMAS J SEIFERT Officer Jan 03 '25 Proposed Sale 112.54 15,000 1,688,100 Jan 03 04:18 PM DOUGLAS KRAMER Officer Jan 02 '25 Proposed Sale 112.45 9,000 1,012,072 Jan 02 04:05 PM Prince Matthew CEO & Chair of the Board Dec 18 '24 Sale 113.00 52,384 5,919,416 10,762 Dec 20 08:42 PM Prince Matthew CEO & Chair of the Board Dec 20 '24 Sale 111.90 52,384 5,861,572 10,762 Dec 20 08:42 PM Prince Matthew CEO & Chair of the Board Dec 19 '24 Sale 108.72 52,384 5,695,092 10,762 Dec 20 08:42 PM SEIFERT THOMAS J Chief Financial Officer Dec 18 '24 Sale 112.72 15,000 1,690,860 252,869 Dec 19 05:19 PM THOMAS J SEIFERT Officer Dec 18 '24 Proposed Sale 117.56 15,000 1,763,400 Dec 18 04:25 PM Zatlyn Michelle President and COO Dec 12 '24 Sale 113.16 25,640 2,901,548 0 Dec 12 08:46 PM Zatlyn Michelle President and COO Dec 11 '24 Sale 112.69 25,640 2,889,457 0 Dec 12 08:46 PM Zatlyn Michelle President and COO Dec 10 '24 Sale 112.68 25,640 2,889,049 0 Dec 12 08:46 PM SEIFERT THOMAS J Chief Financial Officer Dec 04 '24 Sale 109.90 15,000 1,648,496 252,869 Dec 05 05:25 PM THOMAS J SEIFERT Officer Dec 04 '24 Proposed Sale 104.91 15,000 1,573,650 Dec 04 04:41 PM Kramer Douglas James Chief Legal Officer Dec 02 '24 Sale 105.57 3,000 316,710 175,688 Dec 03 04:29 PM DOUGLAS KRAMER Officer Dec 02 '24 Proposed Sale 105.57 3,000 316,710 Dec 02 04:05 PM Zatlyn Michelle President and COO Nov 25 '24 Sale 105.30 35,118 3,697,890 0 Nov 27 07:23 PM Zatlyn Michelle President and COO Nov 26 '24 Sale 104.39 25,640 2,676,675 0 Nov 27 07:23 PM Zatlyn Michelle President and COO Nov 27 '24 Sale 100.44 25,640 2,575,257 0 Nov 27 07:23 PM Michelle Zatlyn Officer Nov 25 '24 Proposed Sale 103.73 240,238 24,919,888 Nov 25 05:08 PM Kramer Douglas James Chief Legal Officer Nov 21 '24 Sale 100.00 6,000 600,000 175,688 Nov 21 04:17 PM DOUGLAS KRAMER Officer Nov 21 '24 Proposed Sale 100.00 6,000 600,000 Nov 21 04:05 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Nov 19 '24 Sale 95.03 28,635 2,721,044 252,869 Nov 19 07:14 PM Riley Janel CHIEF ACCOUNTING OFFICER Nov 18 '24 Sale 90.08 3,495 314,847 73,130 Nov 19 04:46 PM THOMAS J SEIFERT Officer Nov 19 '24 Proposed Sale 92.29 28,635 2,642,724 Nov 19 04:22 PM Prince Matthew CEO & Chair of the Board Nov 13 '24 Sale 95.59 52,384 5,007,175 0 Nov 15 07:59 PM Prince Matthew CEO & Chair of the Board Nov 14 '24 Sale 92.31 52,384 4,835,608 0 Nov 15 07:59 PM Prince Matthew CEO & Chair of the Board Nov 15 '24 Sale 89.06 52,384 4,665,521 0 Nov 15 07:59 PM Matthew Prince Officer Nov 13 '24 Proposed Sale 94.16 471,456 44,392,297 Nov 13 06:27 PM Eitel Maria S Director Nov 01 '24 Sale 88.00 6,875 605,033 5,927 Nov 04 07:16 PM Kramer Douglas James Chief Legal Officer Nov 01 '24 Sale 88.60 3,000 265,800 185,386 Nov 04 05:23 PM SEIFERT THOMAS J Chief Financial Officer Nov 04 '24 Sale 86.79 15,000 1,301,835 281,403 Nov 04 05:21 PM THOMAS J SEIFERT Officer Nov 04 '24 Proposed Sale 87.55 15,000 1,313,250 Nov 04 04:25 PM MARIA EITEL Director Nov 01 '24 Proposed Sale 88.00 6,875 605,033 Nov 01 04:42 PM DOUGLAS KRAMER Officer Nov 01 '24 Proposed Sale 88.60 3,000 265,800 Nov 01 04:37 PM SEIFERT THOMAS J Chief Financial Officer Oct 18 '24 Sale 90.88 15,000 1,363,158 281,403 Oct 21 04:50 PM THOMAS J SEIFERT Officer Oct 18 '24 Proposed Sale 90.40 15,000 1,356,000 Oct 18 04:19 PM Prince Matthew CEO & Chair of the Board Oct 15 '24 Sale 93.95 52,384 4,921,495 10,761 Oct 17 06:35 PM Prince Matthew CEO & Chair of the Board Oct 16 '24 Sale 91.93 52,384 4,815,583 10,761 Oct 17 06:35 PM Prince Matthew CEO & Chair of the Board Oct 17 '24 Sale 90.92 52,384 4,763,010 10,761 Oct 17 06:35 PM Zatlyn Michelle President and COO Oct 07 '24 Sale 81.60 64,100 5,230,592 0 Oct 09 07:48 PM Zatlyn Michelle President and COO Oct 09 '24 Sale 82.60 25,640 2,117,963 0 Oct 09 07:48 PM Zatlyn Michelle President and COO Oct 08 '24 Sale 80.44 25,640 2,062,427 0 Oct 09 07:48 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Oct 03 '24 Sale 79.19 15,000 1,187,865 281,403 Oct 04 05:29 PM THOMAS J SEIFERT Officer Oct 03 '24 Proposed Sale 79.34 15,000 1,190,100 Oct 03 04:27 PM Kramer Douglas James Chief Legal Officer Oct 02 '24 Sale 78.87 3,000 236,610 185,386 Oct 03 04:15 PM DOUGLAS KRAMER Officer Oct 02 '24 Proposed Sale 78.87 3,000 236,610 Oct 02 04:14 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Sep 18 '24 Sale 78.36 15,000 1,175,378 281,403 Sep 19 05:13 PM THOMAS J SEIFERT Officer Sep 18 '24 Proposed Sale 79.11 15,000 1,186,650 Sep 18 04:45 PM Zatlyn Michelle President and COO Sep 09 '24 Sale 77.13 12,820 988,780 0 Sep 11 07:55 PM Zatlyn Michelle President and COO Sep 11 '24 Sale 76.14 12,820 976,168 0 Sep 11 07:55 PM Zatlyn Michelle President and COO Sep 10 '24 Sale 75.63 12,820 969,517 0 Sep 11 07:55 PM Prince Matthew CEO & Chair of the Board Sep 05 '24 Sale 78.51 52,384 4,112,554 10,761 Sep 06 09:03 PM Prince Matthew CEO & Chair of the Board Sep 04 '24 Sale 78.06 52,384 4,089,133 10,761 Sep 06 09:03 PM Prince Matthew CEO & Chair of the Board Sep 06 '24 Sale 76.55 52,384 4,009,768 10,761 Sep 06 09:03 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Sep 04 '24 Sale 78.05 15,000 1,170,818 281,403 Sep 05 04:35 PM Kramer Douglas James CHIEF LEGAL OFFICER Sep 03 '24 Sale 81.53 3,000 244,590 185,386 Sep 04 04:26 PM THOMAS J SEIFERT Officer Sep 04 '24 Proposed Sale 78.11 15,000 1,171,650 Sep 04 04:14 PM DOUGLAS KRAMER Officer Sep 03 '24 Proposed Sale 81.53 3,000 244,590 Sep 03 04:15 PM Zatlyn Michelle President and COO Aug 20 '24 Sale 83.74 35,117 2,940,717 0 Aug 22 07:23 PM Zatlyn Michelle President and COO Aug 22 '24 Sale 81.91 25,640 2,100,243 0 Aug 22 07:23 PM Zatlyn Michelle President and COO Aug 21 '24 Sale 81.74 25,640 2,095,826 0 Aug 22 07:23 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Aug 20 '24 Sale 82.84 28,636 2,372,117 281,403 Aug 22 04:12 PM Michelle Zatlyn Officer Aug 20 '24 Proposed Sale 82.38 240,237 19,790,724 Aug 20 04:46 PM THOMAS J SEIFERT Officer Aug 20 '24 Proposed Sale 84.07 28,636 2,407,429 Aug 20 04:29 PM Riley Janel CHIEF ACCOUNTING OFFICER May 29 '24 Sale 73.47 17,938 1,317,982 87,270 Aug 16 05:19 PM Riley Janel CHIEF ACCOUNTING OFFICER Aug 16 '24 Sale 81.65 3,495 285,375 80,183 Aug 16 05:19 PM Prince Matthew CEO & Chair of the Board Aug 07 '24 Sale 78.17 52,384 4,094,614 0 Aug 09 07:05 PM Prince Matthew CEO & Chair of the Board Aug 09 '24 Sale 77.86 52,384 4,078,387 0 Aug 09 07:05 PM Prince Matthew CEO & Chair of the Board Aug 08 '24 Sale 76.70 52,384 4,017,884 0 Aug 09 07:05 PM Matthew Prince Officer Aug 07 '24 Proposed Sale 76.37 471,456 36,005,095 Aug 07 05:12 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Aug 02 '24 Sale 78.71 15,000 1,180,714 309,937 Aug 05 05:30 PM THOMAS J SEIFERT Officer Aug 02 '24 Proposed Sale 74.40 15,000 1,116,000 Aug 02 04:21 PM Kramer Douglas James CHIEF LEGAL OFFICER Aug 01 '24 Sale 77.17 3,000 231,510 195,303 Aug 02 04:16 PM Eitel Maria S Director Aug 01 '24 Sale 77.68 6,875 534,016 12,802 Aug 02 04:07 PM DOUGLAS KRAMER Officer Aug 01 '24 Proposed Sale 77.17 3,000 231,510 Aug 01 04:25 PM MARIA EITEL Director Aug 01 '24 Proposed Sale 77.68 6,875 534,016 Aug 01 04:16 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Jul 18 '24 Sale 78.89 15,000 1,183,382 309,937 Jul 19 05:35 PM Prince Matthew CEO & Chair of the Board Jul 09 '24 Sale 82.96 52,384 4,345,580 8,742 Jul 11 07:09 PM
Index RUT P/E - EPS (ttm) -0.44 Insider Own 49.04% Shs Outstand 170.84M Perf Week -4.95%
Market Cap 461.65M Forward P/E - EPS next Y -0.49 Insider Trans 0.04% Shs Float 87.45M Perf Month -2.89%
Income -82.94M PEG - EPS next Q -0.11 Inst Own 52.86% Short Float 17.41% Perf Quarter -9.12%
Sales 0.00M P/S - EPS this Y -39.77% Inst Trans -2.25% Short Ratio 14.63 Perf Half Y -40.22%
Book/sh 1.17 P/B 2.31 EPS next Y -5.42% ROA -39.41% Short Interest 15.23M Perf Year -44.19%
Cash/sh 1.28 P/C 2.10 EPS next 5Y 8.84% ROE -47.95% 52W Range 2.59 - 5.70 Perf YTD -12.38%
Dividend Est. - P/FCF - EPS past 5Y 29.09% ROI -36.71% 52W High -52.81% Beta 0.58
Dividend TTM - Quick Ratio 17.70 Sales past 5Y -25.00% Gross Margin - 52W Low 3.86% ATR (14) 0.14
Dividend Ex-Date - Current Ratio 17.70 EPS Y/Y TTM -39.95% Oper. Margin - RSI (14) 40.82 Volatility 4.10% 4.99%
Employees 37 Debt/Eq 0.13 Sales Y/Y TTM - Profit Margin - Recom 1.25 Target Price 9.56
Option/Short Yes / Yes LT Debt/Eq 0.13 EPS Q/Q -13.37% Payout - Rel Volume 0.67 Prev Close 2.69
Sales Surprise - EPS Surprise -1.29% Sales Q/Q - Earnings Nov 12 BMO Avg Volume 1.04M Price 2.69
SMA20 -2.91% SMA50 -9.36% SMA200 -29.52% Trades
Volume 692,862 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-20-24 Initiated Wells Fargo
Overweight
$8
Nov-13-24 Downgrade Evercore ISI
Outperform → In-line
$7 → $5
Feb-15-24 Initiated JMP Securities
Mkt Outperform
$8
Nov-07-23 Initiated Guggenheim
Buy
$7
May-16-23 Upgrade Jefferies
Hold → Buy
$2 → $4
Mar-31-23 Downgrade Jefferies
Buy → Hold
$2
Mar-16-21 Initiated Piper Sandler
Overweight
$7
Mar-15-21 Initiated Oppenheimer
Outperform
$4
Jun-13-19 Reiterated H.C. Wainwright
Buy
$22 → $6
Jun-13-19 Downgrade Ladenburg Thalmann
Buy → Neutral
$21 → $3
Jun-13-19 Downgrade JMP Securities
Mkt Outperform → Mkt Perform
Aug-13-18 Resumed ROTH Capital
Neutral
$12
Jan-03-18 Initiated Ladenburg Thalmann
Buy
$35
Sep-27-17 Resumed ROTH Capital
Buy
$40
Sep-22-17 Initiated Jefferies
Buy
$20
Sep-11-17 Initiated JMP Securities
Mkt Outperform
$20
Show Previous Ratings
Feb-14-25 04:05PM
Jan-30-25 08:39AM
Jan-29-25 04:05PM
Dec-23-24 04:05PM
Dec-18-24 04:05PM
(Business Wire) -6.21%
+6.95%
04:05PM
Loading…
Dec-17-24 04:05PM
Nov-22-24 04:05PM
08:05AM
Nov-13-24 01:21PM
08:05AM
Nov-12-24 08:05AM
Nov-04-24 04:05PM
Oct-22-24 08:05AM
Oct-18-24 04:05PM
Oct-01-24 08:05AM
04:05PM
Loading…
Sep-27-24 04:05PM
08:05AM
Sep-24-24 08:05AM
Sep-23-24 08:05AM
Sep-08-24 06:45AM
Sep-06-24 04:05PM
Sep-03-24 04:05PM
Sep-01-24 10:26PM
Aug-29-24 08:41PM
Aug-16-24 04:05PM
Aug-15-24 08:05AM
Aug-12-24 04:05PM
Jun-29-24 08:35PM
06:30PM
Jun-28-24 08:50AM
07:41AM
Loading…
Jun-26-24 07:41AM
06:30AM
Jun-25-24 08:05PM
Jun-19-24 09:00AM
Jun-11-24 06:00AM
May-29-24 08:05AM
May-21-24 08:20AM
May-19-24 12:15PM
May-16-24 04:05PM
May-09-24 10:55PM
04:05PM
May-07-24 04:05PM
(Business Wire) +6.26%
-5.13%
Apr-08-24 08:05AM
Mar-22-24 04:05PM
Mar-07-24 10:54PM
04:05PM
Mar-06-24 04:05PM
Feb-02-24 08:05AM
Jan-31-24 08:05AM
Dec-30-23 03:01PM
Dec-21-23 08:05AM
Dec-20-23 08:05AM
Dec-15-23 04:05PM
Nov-21-23 08:05AM
Nov-09-23 04:05PM
Nov-08-23 04:05PM
Oct-06-23 04:05PM
Sep-27-23 07:29PM
Sep-17-23 10:54AM
Sep-12-23 09:12AM
Sep-05-23 04:05PM
Aug-10-23 04:05PM
Aug-04-23 04:05PM
Jul-13-23 07:00AM
Jun-26-23 04:05PM
08:05AM
Jun-02-23 08:05AM
May-28-23 08:26AM
May-16-23 12:32PM
May-15-23 08:05AM
May-05-23 04:05PM
Apr-03-23 07:33AM
Mar-31-23 04:05PM
Mar-30-23 04:05PM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 04:05PM
07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 06:01AM
Feb-28-23 04:05PM
06:43AM
Feb-27-23 06:50AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 06:27AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
06:24AM
Feb-14-23 08:05AM
06:23AM
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lowrance David L Chief Financial Officer Dec 16 '24 Sale 3.33 25,000 83,278 381,005 Dec 16 05:59 PM Pauls Matthew CHIEF EXECUTIVE OFFICER Dec 16 '24 Sale 3.31 54,702 180,828 1,536,379 Dec 16 05:56 PM Hawkins Richard J Director Dec 16 '24 Sale 3.32 8,000 26,569 67,241 Dec 16 05:53 PM Pauls Matthew Director Dec 16 '24 Proposed Sale 3.31 54,702 180,800 Dec 16 05:13 PM Hawkins Richard J Director Dec 16 '24 Proposed Sale 3.29 8,000 26,300 Dec 16 03:15 PM Lowrance David L Officer Dec 16 '24 Proposed Sale 3.30 25,000 82,500 Dec 16 03:08 PM McCracken Joseph S Director Nov 19 '24 Buy 2.95 20,000 59,072 210,837 Nov 20 07:55 AM RAMSAY DAVID A Director Nov 18 '24 Buy 2.88 100,000 287,600 2,323,642 Nov 18 12:33 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
